Eculizumab treatment efficiently prevents C5 cleavage without C5a generation in vivo

Blood. 2015 Jul 9;126(2):278-9. doi: 10.1182/blood-2015-03-637645.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Complement C5a / immunology*
  • Female
  • HELLP Syndrome / therapy*
  • Humans
  • Pregnancy

Substances

  • Antibodies, Monoclonal, Humanized
  • Complement C5a